Global Volatile Anaesthetic Agents Market Growth 2026-2032
The global Volatile Anaesthetic Agents market size is predicted to grow from US$ 1032 million in 2025 to US$ 1356 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.
Volatile Anaesthetic Agents are volatile liquids or gases that are breathed in through the lungs to produce and maintain general anaesthesia, causing a controlled, reversible state of unconsciousness along with reduced pain perception, amnesia, and suppression of movement and reflexes during surgery or procedures. They are delivered via an anaesthesia machine and vaporizer (for volatile liquids) or as a medical gas, mixed with oxygen or air and titrated in real time by adjusting the inspired concentration; their clinical effect depends largely on how they move from the lungs into the bloodstream and then the brain, which is influenced by factors like blood?gas solubility (speed of onset and recovery), ventilation, and cardiac output. Common examples include sevoflurane, isoflurane, desflurane, and nitrous oxide, chosen based on desired speed, haemodynamic stability, airway tolerance, and patient factors; while generally safe under monitoring, they can cause side effects such as low blood pressure, respiratory depression, postoperative nausea and vomiting, and?rarely?malignant hyperthermia in susceptible individuals. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.
Upstream for Volatile Anaesthetic Agents begins with basic petrochemical feedstocks that are converted into highly fluorinated/halogenated intermediates using specialty reagents (notably fluorinating and chlorinating agents), catalysts, and tightly controlled reaction and purification steps, because these products must meet very high purity and stability requirements under pharmaceutical GMP; manufacturers then distill and dry the anesthetic to specification, perform rigorous QC (impurities, water content, identity), and fill it into dedicated, moisture-tight bottles/canisters with compliant labeling and cold-chain-free but controlled logistics. Downstream, finished product moves through pharma wholesalers and hospital procurement channels to operating rooms and ambulatory surgery centers, where it is used with anesthesia machines and calibrated vaporizers (plus carrier gases) and supported by consumables and infrastructure such as breathing circuits, CO? absorbents, and waste-gas scavenging systems; used anesthetic largely leaves the patient via exhalation and is routed into scavenging/disposal pathways (increasingly with capture/destruction or monitoring in some facilities), while ongoing demand is driven by surgical volumes, formulary choices, and workplace exposure and environmental management practices.
United States market for Volatile Anaesthetic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Volatile Anaesthetic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Volatile Anaesthetic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Volatile Anaesthetic Agents players cover Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Volatile Anaesthetic Agents Industry Forecast? looks at past sales and reviews total world Volatile Anaesthetic Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected Volatile Anaesthetic Agents sales for 2026 through 2032. With Volatile Anaesthetic Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Volatile Anaesthetic Agents industry.
This Insight Report provides a comprehensive analysis of the global Volatile Anaesthetic Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Volatile Anaesthetic Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Volatile Anaesthetic Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Volatile Anaesthetic Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Volatile Anaesthetic Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Volatile Anaesthetic Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Volatile Anaesthetic Agents are volatile liquids or gases that are breathed in through the lungs to produce and maintain general anaesthesia, causing a controlled, reversible state of unconsciousness along with reduced pain perception, amnesia, and suppression of movement and reflexes during surgery or procedures. They are delivered via an anaesthesia machine and vaporizer (for volatile liquids) or as a medical gas, mixed with oxygen or air and titrated in real time by adjusting the inspired concentration; their clinical effect depends largely on how they move from the lungs into the bloodstream and then the brain, which is influenced by factors like blood?gas solubility (speed of onset and recovery), ventilation, and cardiac output. Common examples include sevoflurane, isoflurane, desflurane, and nitrous oxide, chosen based on desired speed, haemodynamic stability, airway tolerance, and patient factors; while generally safe under monitoring, they can cause side effects such as low blood pressure, respiratory depression, postoperative nausea and vomiting, and?rarely?malignant hyperthermia in susceptible individuals. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.
Upstream for Volatile Anaesthetic Agents begins with basic petrochemical feedstocks that are converted into highly fluorinated/halogenated intermediates using specialty reagents (notably fluorinating and chlorinating agents), catalysts, and tightly controlled reaction and purification steps, because these products must meet very high purity and stability requirements under pharmaceutical GMP; manufacturers then distill and dry the anesthetic to specification, perform rigorous QC (impurities, water content, identity), and fill it into dedicated, moisture-tight bottles/canisters with compliant labeling and cold-chain-free but controlled logistics. Downstream, finished product moves through pharma wholesalers and hospital procurement channels to operating rooms and ambulatory surgery centers, where it is used with anesthesia machines and calibrated vaporizers (plus carrier gases) and supported by consumables and infrastructure such as breathing circuits, CO? absorbents, and waste-gas scavenging systems; used anesthetic largely leaves the patient via exhalation and is routed into scavenging/disposal pathways (increasingly with capture/destruction or monitoring in some facilities), while ongoing demand is driven by surgical volumes, formulary choices, and workplace exposure and environmental management practices.
United States market for Volatile Anaesthetic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Volatile Anaesthetic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Volatile Anaesthetic Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Volatile Anaesthetic Agents players cover Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Volatile Anaesthetic Agents Industry Forecast? looks at past sales and reviews total world Volatile Anaesthetic Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected Volatile Anaesthetic Agents sales for 2026 through 2032. With Volatile Anaesthetic Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Volatile Anaesthetic Agents industry.
This Insight Report provides a comprehensive analysis of the global Volatile Anaesthetic Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Volatile Anaesthetic Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Volatile Anaesthetic Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Volatile Anaesthetic Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Volatile Anaesthetic Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Volatile Anaesthetic Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Heptafluoroane
- Desflurane
- Isoflurane
- Others
- Below 3%
- Above 3%
- Human Use
- Animal Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter
- AbbVie
- Piramal Critical Care
- Fresenius Kabi
- Halocarbon
- Aspen
- Pfizer
- Maruishi Pharmaceutical
- Jiangsu Hengrui Medicine
- Lunan Pharmaceutical
- Hikma Pharmaceuticals
- HeBei YiPin Pharmaceutical
- Dechra Pharmaceuticals
- Life Sciences
- Zhejiang AngLiKang Pharmaceutical
- Linde Healthcare
- Air Liquide
- Messer
- What is the 10-year outlook for the global Volatile Anaesthetic Agents market?
- What factors are driving Volatile Anaesthetic Agents market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Volatile Anaesthetic Agents market opportunities vary by end market size?
- How does Volatile Anaesthetic Agents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Volatile Anaesthetic Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Volatile Anaesthetic Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Volatile Anaesthetic Agents by Country/Region, 2021, 2025 & 2032
2.2 Volatile Anaesthetic Agents Segment by Type
2.2.1 Heptafluoroane
2.2.2 Desflurane
2.2.3 Isoflurane
2.2.4 Others
2.2.5 Volatile Anaesthetic Agents Sales by Type
2.2.5.1 Global Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
2.2.5.2 Global Volatile Anaesthetic Agents Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Volatile Anaesthetic Agents Sale Price by Type (2021-2026)
2.3 Volatile Anaesthetic Agents Segment by MAC
2.3.1 Below 3%
2.3.2 Above 3%
2.3.3 Volatile Anaesthetic Agents Sales by MAC
2.3.3.1 Global Volatile Anaesthetic Agents Sales Market Share by MAC (2021-2026)
2.3.3.2 Global Volatile Anaesthetic Agents Revenue and Market Share by MAC (2021-2026)
2.3.3.3 Global Volatile Anaesthetic Agents Sale Price by MAC (2021-2026)
2.4 Volatile Anaesthetic Agents Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.4.3 Volatile Anaesthetic Agents Sales by Application
2.4.3.1 Global Volatile Anaesthetic Agents Sale Market Share by Application (2021-2026)
2.4.3.2 Global Volatile Anaesthetic Agents Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Volatile Anaesthetic Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Volatile Anaesthetic Agents Breakdown Data by Company
3.1.1 Global Volatile Anaesthetic Agents Annual Sales by Company (2021-2026)
3.1.2 Global Volatile Anaesthetic Agents Sales Market Share by Company (2021-2026)
3.2 Global Volatile Anaesthetic Agents Annual Revenue by Company (2021-2026)
3.2.1 Global Volatile Anaesthetic Agents Revenue by Company (2021-2026)
3.2.2 Global Volatile Anaesthetic Agents Revenue Market Share by Company (2021-2026)
3.3 Global Volatile Anaesthetic Agents Sale Price by Company
3.4 Key Manufacturers Volatile Anaesthetic Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Volatile Anaesthetic Agents Product Location Distribution
3.4.2 Players Volatile Anaesthetic Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VOLATILE ANAESTHETIC AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Volatile Anaesthetic Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global Volatile Anaesthetic Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Volatile Anaesthetic Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Volatile Anaesthetic Agents Market Size by Country/Region (2021-2026)
4.2.1 Global Volatile Anaesthetic Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Volatile Anaesthetic Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Volatile Anaesthetic Agents Sales Growth
4.4 APAC Volatile Anaesthetic Agents Sales Growth
4.5 Europe Volatile Anaesthetic Agents Sales Growth
4.6 Middle East & Africa Volatile Anaesthetic Agents Sales Growth
5 AMERICAS
5.1 Americas Volatile Anaesthetic Agents Sales by Country
5.1.1 Americas Volatile Anaesthetic Agents Sales by Country (2021-2026)
5.1.2 Americas Volatile Anaesthetic Agents Revenue by Country (2021-2026)
5.2 Americas Volatile Anaesthetic Agents Sales by Type (2021-2026)
5.3 Americas Volatile Anaesthetic Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Volatile Anaesthetic Agents Sales by Region
6.1.1 APAC Volatile Anaesthetic Agents Sales by Region (2021-2026)
6.1.2 APAC Volatile Anaesthetic Agents Revenue by Region (2021-2026)
6.2 APAC Volatile Anaesthetic Agents Sales by Type (2021-2026)
6.3 APAC Volatile Anaesthetic Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Volatile Anaesthetic Agents by Country
7.1.1 Europe Volatile Anaesthetic Agents Sales by Country (2021-2026)
7.1.2 Europe Volatile Anaesthetic Agents Revenue by Country (2021-2026)
7.2 Europe Volatile Anaesthetic Agents Sales by Type (2021-2026)
7.3 Europe Volatile Anaesthetic Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Volatile Anaesthetic Agents by Country
8.1.1 Middle East & Africa Volatile Anaesthetic Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Volatile Anaesthetic Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa Volatile Anaesthetic Agents Sales by Type (2021-2026)
8.3 Middle East & Africa Volatile Anaesthetic Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Volatile Anaesthetic Agents
10.3 Manufacturing Process Analysis of Volatile Anaesthetic Agents
10.4 Industry Chain Structure of Volatile Anaesthetic Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Volatile Anaesthetic Agents Distributors
11.3 Volatile Anaesthetic Agents Customer
12 WORLD FORECAST REVIEW FOR VOLATILE ANAESTHETIC AGENTS BY GEOGRAPHIC REGION
12.1 Global Volatile Anaesthetic Agents Market Size Forecast by Region
12.1.1 Global Volatile Anaesthetic Agents Forecast by Region (2027-2032)
12.1.2 Global Volatile Anaesthetic Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Volatile Anaesthetic Agents Forecast by Type (2027-2032)
12.7 Global Volatile Anaesthetic Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Volatile Anaesthetic Agents Product Portfolios and Specifications
13.1.3 Baxter Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Volatile Anaesthetic Agents Product Portfolios and Specifications
13.2.3 AbbVie Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Piramal Critical Care
13.3.1 Piramal Critical Care Company Information
13.3.2 Piramal Critical Care Volatile Anaesthetic Agents Product Portfolios and Specifications
13.3.3 Piramal Critical Care Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Piramal Critical Care Main Business Overview
13.3.5 Piramal Critical Care Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Volatile Anaesthetic Agents Product Portfolios and Specifications
13.4.3 Fresenius Kabi Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Halocarbon
13.5.1 Halocarbon Company Information
13.5.2 Halocarbon Volatile Anaesthetic Agents Product Portfolios and Specifications
13.5.3 Halocarbon Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Halocarbon Main Business Overview
13.5.5 Halocarbon Latest Developments
13.6 Aspen
13.6.1 Aspen Company Information
13.6.2 Aspen Volatile Anaesthetic Agents Product Portfolios and Specifications
13.6.3 Aspen Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Aspen Main Business Overview
13.6.5 Aspen Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Volatile Anaesthetic Agents Product Portfolios and Specifications
13.7.3 Pfizer Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Maruishi Pharmaceutical
13.8.1 Maruishi Pharmaceutical Company Information
13.8.2 Maruishi Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
13.8.3 Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Maruishi Pharmaceutical Main Business Overview
13.8.5 Maruishi Pharmaceutical Latest Developments
13.9 Jiangsu Hengrui Medicine
13.9.1 Jiangsu Hengrui Medicine Company Information
13.9.2 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product Portfolios and Specifications
13.9.3 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jiangsu Hengrui Medicine Main Business Overview
13.9.5 Jiangsu Hengrui Medicine Latest Developments
13.10 Lunan Pharmaceutical
13.10.1 Lunan Pharmaceutical Company Information
13.10.2 Lunan Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
13.10.3 Lunan Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lunan Pharmaceutical Main Business Overview
13.10.5 Lunan Pharmaceutical Latest Developments
13.11 Hikma Pharmaceuticals
13.11.1 Hikma Pharmaceuticals Company Information
13.11.2 Hikma Pharmaceuticals Volatile Anaesthetic Agents Product Portfolios and Specifications
13.11.3 Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hikma Pharmaceuticals Main Business Overview
13.11.5 Hikma Pharmaceuticals Latest Developments
13.12 HeBei YiPin Pharmaceutical
13.12.1 HeBei YiPin Pharmaceutical Company Information
13.12.2 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
13.12.3 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 HeBei YiPin Pharmaceutical Main Business Overview
13.12.5 HeBei YiPin Pharmaceutical Latest Developments
13.13 Dechra Pharmaceuticals
13.13.1 Dechra Pharmaceuticals Company Information
13.13.2 Dechra Pharmaceuticals Volatile Anaesthetic Agents Product Portfolios and Specifications
13.13.3 Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Dechra Pharmaceuticals Main Business Overview
13.13.5 Dechra Pharmaceuticals Latest Developments
13.14 Life Sciences
13.14.1 Life Sciences Company Information
13.14.2 Life Sciences Volatile Anaesthetic Agents Product Portfolios and Specifications
13.14.3 Life Sciences Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Life Sciences Main Business Overview
13.14.5 Life Sciences Latest Developments
13.15 Zhejiang AngLiKang Pharmaceutical
13.15.1 Zhejiang AngLiKang Pharmaceutical Company Information
13.15.2 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
13.15.3 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Zhejiang AngLiKang Pharmaceutical Main Business Overview
13.15.5 Zhejiang AngLiKang Pharmaceutical Latest Developments
13.16 Linde Healthcare
13.16.1 Linde Healthcare Company Information
13.16.2 Linde Healthcare Volatile Anaesthetic Agents Product Portfolios and Specifications
13.16.3 Linde Healthcare Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Linde Healthcare Main Business Overview
13.16.5 Linde Healthcare Latest Developments
13.17 Air Liquide
13.17.1 Air Liquide Company Information
13.17.2 Air Liquide Volatile Anaesthetic Agents Product Portfolios and Specifications
13.17.3 Air Liquide Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Air Liquide Main Business Overview
13.17.5 Air Liquide Latest Developments
13.18 Messer
13.18.1 Messer Company Information
13.18.2 Messer Volatile Anaesthetic Agents Product Portfolios and Specifications
13.18.3 Messer Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Messer Main Business Overview
13.18.5 Messer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Volatile Anaesthetic Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Volatile Anaesthetic Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Volatile Anaesthetic Agents by Country/Region, 2021, 2025 & 2032
2.2 Volatile Anaesthetic Agents Segment by Type
2.2.1 Heptafluoroane
2.2.2 Desflurane
2.2.3 Isoflurane
2.2.4 Others
2.2.5 Volatile Anaesthetic Agents Sales by Type
2.2.5.1 Global Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
2.2.5.2 Global Volatile Anaesthetic Agents Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Volatile Anaesthetic Agents Sale Price by Type (2021-2026)
2.3 Volatile Anaesthetic Agents Segment by MAC
2.3.1 Below 3%
2.3.2 Above 3%
2.3.3 Volatile Anaesthetic Agents Sales by MAC
2.3.3.1 Global Volatile Anaesthetic Agents Sales Market Share by MAC (2021-2026)
2.3.3.2 Global Volatile Anaesthetic Agents Revenue and Market Share by MAC (2021-2026)
2.3.3.3 Global Volatile Anaesthetic Agents Sale Price by MAC (2021-2026)
2.4 Volatile Anaesthetic Agents Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.4.3 Volatile Anaesthetic Agents Sales by Application
2.4.3.1 Global Volatile Anaesthetic Agents Sale Market Share by Application (2021-2026)
2.4.3.2 Global Volatile Anaesthetic Agents Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Volatile Anaesthetic Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Volatile Anaesthetic Agents Breakdown Data by Company
3.1.1 Global Volatile Anaesthetic Agents Annual Sales by Company (2021-2026)
3.1.2 Global Volatile Anaesthetic Agents Sales Market Share by Company (2021-2026)
3.2 Global Volatile Anaesthetic Agents Annual Revenue by Company (2021-2026)
3.2.1 Global Volatile Anaesthetic Agents Revenue by Company (2021-2026)
3.2.2 Global Volatile Anaesthetic Agents Revenue Market Share by Company (2021-2026)
3.3 Global Volatile Anaesthetic Agents Sale Price by Company
3.4 Key Manufacturers Volatile Anaesthetic Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Volatile Anaesthetic Agents Product Location Distribution
3.4.2 Players Volatile Anaesthetic Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VOLATILE ANAESTHETIC AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Volatile Anaesthetic Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global Volatile Anaesthetic Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Volatile Anaesthetic Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Volatile Anaesthetic Agents Market Size by Country/Region (2021-2026)
4.2.1 Global Volatile Anaesthetic Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Volatile Anaesthetic Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Volatile Anaesthetic Agents Sales Growth
4.4 APAC Volatile Anaesthetic Agents Sales Growth
4.5 Europe Volatile Anaesthetic Agents Sales Growth
4.6 Middle East & Africa Volatile Anaesthetic Agents Sales Growth
5 AMERICAS
5.1 Americas Volatile Anaesthetic Agents Sales by Country
5.1.1 Americas Volatile Anaesthetic Agents Sales by Country (2021-2026)
5.1.2 Americas Volatile Anaesthetic Agents Revenue by Country (2021-2026)
5.2 Americas Volatile Anaesthetic Agents Sales by Type (2021-2026)
5.3 Americas Volatile Anaesthetic Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Volatile Anaesthetic Agents Sales by Region
6.1.1 APAC Volatile Anaesthetic Agents Sales by Region (2021-2026)
6.1.2 APAC Volatile Anaesthetic Agents Revenue by Region (2021-2026)
6.2 APAC Volatile Anaesthetic Agents Sales by Type (2021-2026)
6.3 APAC Volatile Anaesthetic Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Volatile Anaesthetic Agents by Country
7.1.1 Europe Volatile Anaesthetic Agents Sales by Country (2021-2026)
7.1.2 Europe Volatile Anaesthetic Agents Revenue by Country (2021-2026)
7.2 Europe Volatile Anaesthetic Agents Sales by Type (2021-2026)
7.3 Europe Volatile Anaesthetic Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Volatile Anaesthetic Agents by Country
8.1.1 Middle East & Africa Volatile Anaesthetic Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Volatile Anaesthetic Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa Volatile Anaesthetic Agents Sales by Type (2021-2026)
8.3 Middle East & Africa Volatile Anaesthetic Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Volatile Anaesthetic Agents
10.3 Manufacturing Process Analysis of Volatile Anaesthetic Agents
10.4 Industry Chain Structure of Volatile Anaesthetic Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Volatile Anaesthetic Agents Distributors
11.3 Volatile Anaesthetic Agents Customer
12 WORLD FORECAST REVIEW FOR VOLATILE ANAESTHETIC AGENTS BY GEOGRAPHIC REGION
12.1 Global Volatile Anaesthetic Agents Market Size Forecast by Region
12.1.1 Global Volatile Anaesthetic Agents Forecast by Region (2027-2032)
12.1.2 Global Volatile Anaesthetic Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Volatile Anaesthetic Agents Forecast by Type (2027-2032)
12.7 Global Volatile Anaesthetic Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Volatile Anaesthetic Agents Product Portfolios and Specifications
13.1.3 Baxter Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Volatile Anaesthetic Agents Product Portfolios and Specifications
13.2.3 AbbVie Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Piramal Critical Care
13.3.1 Piramal Critical Care Company Information
13.3.2 Piramal Critical Care Volatile Anaesthetic Agents Product Portfolios and Specifications
13.3.3 Piramal Critical Care Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Piramal Critical Care Main Business Overview
13.3.5 Piramal Critical Care Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Volatile Anaesthetic Agents Product Portfolios and Specifications
13.4.3 Fresenius Kabi Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Halocarbon
13.5.1 Halocarbon Company Information
13.5.2 Halocarbon Volatile Anaesthetic Agents Product Portfolios and Specifications
13.5.3 Halocarbon Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Halocarbon Main Business Overview
13.5.5 Halocarbon Latest Developments
13.6 Aspen
13.6.1 Aspen Company Information
13.6.2 Aspen Volatile Anaesthetic Agents Product Portfolios and Specifications
13.6.3 Aspen Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Aspen Main Business Overview
13.6.5 Aspen Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Volatile Anaesthetic Agents Product Portfolios and Specifications
13.7.3 Pfizer Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Maruishi Pharmaceutical
13.8.1 Maruishi Pharmaceutical Company Information
13.8.2 Maruishi Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
13.8.3 Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Maruishi Pharmaceutical Main Business Overview
13.8.5 Maruishi Pharmaceutical Latest Developments
13.9 Jiangsu Hengrui Medicine
13.9.1 Jiangsu Hengrui Medicine Company Information
13.9.2 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product Portfolios and Specifications
13.9.3 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jiangsu Hengrui Medicine Main Business Overview
13.9.5 Jiangsu Hengrui Medicine Latest Developments
13.10 Lunan Pharmaceutical
13.10.1 Lunan Pharmaceutical Company Information
13.10.2 Lunan Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
13.10.3 Lunan Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lunan Pharmaceutical Main Business Overview
13.10.5 Lunan Pharmaceutical Latest Developments
13.11 Hikma Pharmaceuticals
13.11.1 Hikma Pharmaceuticals Company Information
13.11.2 Hikma Pharmaceuticals Volatile Anaesthetic Agents Product Portfolios and Specifications
13.11.3 Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hikma Pharmaceuticals Main Business Overview
13.11.5 Hikma Pharmaceuticals Latest Developments
13.12 HeBei YiPin Pharmaceutical
13.12.1 HeBei YiPin Pharmaceutical Company Information
13.12.2 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
13.12.3 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 HeBei YiPin Pharmaceutical Main Business Overview
13.12.5 HeBei YiPin Pharmaceutical Latest Developments
13.13 Dechra Pharmaceuticals
13.13.1 Dechra Pharmaceuticals Company Information
13.13.2 Dechra Pharmaceuticals Volatile Anaesthetic Agents Product Portfolios and Specifications
13.13.3 Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Dechra Pharmaceuticals Main Business Overview
13.13.5 Dechra Pharmaceuticals Latest Developments
13.14 Life Sciences
13.14.1 Life Sciences Company Information
13.14.2 Life Sciences Volatile Anaesthetic Agents Product Portfolios and Specifications
13.14.3 Life Sciences Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Life Sciences Main Business Overview
13.14.5 Life Sciences Latest Developments
13.15 Zhejiang AngLiKang Pharmaceutical
13.15.1 Zhejiang AngLiKang Pharmaceutical Company Information
13.15.2 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
13.15.3 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Zhejiang AngLiKang Pharmaceutical Main Business Overview
13.15.5 Zhejiang AngLiKang Pharmaceutical Latest Developments
13.16 Linde Healthcare
13.16.1 Linde Healthcare Company Information
13.16.2 Linde Healthcare Volatile Anaesthetic Agents Product Portfolios and Specifications
13.16.3 Linde Healthcare Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Linde Healthcare Main Business Overview
13.16.5 Linde Healthcare Latest Developments
13.17 Air Liquide
13.17.1 Air Liquide Company Information
13.17.2 Air Liquide Volatile Anaesthetic Agents Product Portfolios and Specifications
13.17.3 Air Liquide Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Air Liquide Main Business Overview
13.17.5 Air Liquide Latest Developments
13.18 Messer
13.18.1 Messer Company Information
13.18.2 Messer Volatile Anaesthetic Agents Product Portfolios and Specifications
13.18.3 Messer Volatile Anaesthetic Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Messer Main Business Overview
13.18.5 Messer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Volatile Anaesthetic Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Volatile Anaesthetic Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Heptafluoroane
Table 4. Major Players of Desflurane
Table 5. Major Players of Isoflurane
Table 6. Major Players of Others
Table 7. Global Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 8. Global Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Table 9. Global Volatile Anaesthetic Agents Revenue by Type (2021-2026) & ($ million)
Table 10. Global Volatile Anaesthetic Agents Revenue Market Share by Type (2021-2026)
Table 11. Global Volatile Anaesthetic Agents Sale Price by Type (2021-2026) & (US$/kg)
Table 12. Major Players of Below 3%
Table 13. Major Players of Above 3%
Table 14. Global Volatile Anaesthetic Agents Sales by MAC (2021-2026) & (Tons)
Table 15. Global Volatile Anaesthetic Agents Sales Market Share by MAC (2021-2026)
Table 16. Global Volatile Anaesthetic Agents Revenue by MAC (2021-2026) & ($ million)
Table 17. Global Volatile Anaesthetic Agents Revenue Market Share by MAC (2021-2026)
Table 18. Global Volatile Anaesthetic Agents Sale Price by MAC (2021-2026) & (US$/kg)
Table 19. Global Volatile Anaesthetic Agents Sale by Application (2021-2026) & (Tons)
Table 20. Global Volatile Anaesthetic Agents Sale Market Share by Application (2021-2026)
Table 21. Global Volatile Anaesthetic Agents Revenue by Application (2021-2026) & ($ million)
Table 22. Global Volatile Anaesthetic Agents Revenue Market Share by Application (2021-2026)
Table 23. Global Volatile Anaesthetic Agents Sale Price by Application (2021-2026) & (US$/kg)
Table 24. Global Volatile Anaesthetic Agents Sales by Company (2021-2026) & (Tons)
Table 25. Global Volatile Anaesthetic Agents Sales Market Share by Company (2021-2026)
Table 26. Global Volatile Anaesthetic Agents Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Volatile Anaesthetic Agents Revenue Market Share by Company (2021-2026)
Table 28. Global Volatile Anaesthetic Agents Sale Price by Company (2021-2026) & (US$/kg)
Table 29. Key Manufacturers Volatile Anaesthetic Agents Producing Area Distribution and Sales Area
Table 30. Players Volatile Anaesthetic Agents Products Offered
Table 31. Volatile Anaesthetic Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Volatile Anaesthetic Agents Sales by Geographic Region (2021-2026) & (Tons)
Table 35. Global Volatile Anaesthetic Agents Sales Market Share Geographic Region (2021-2026)
Table 36. Global Volatile Anaesthetic Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Volatile Anaesthetic Agents Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Volatile Anaesthetic Agents Sales by Country/Region (2021-2026) & (Tons)
Table 39. Global Volatile Anaesthetic Agents Sales Market Share by Country/Region (2021-2026)
Table 40. Global Volatile Anaesthetic Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Volatile Anaesthetic Agents Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Volatile Anaesthetic Agents Sales by Country (2021-2026) & (Tons)
Table 43. Americas Volatile Anaesthetic Agents Sales Market Share by Country (2021-2026)
Table 44. Americas Volatile Anaesthetic Agents Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 46. Americas Volatile Anaesthetic Agents Sales by Application (2021-2026) & (Tons)
Table 47. APAC Volatile Anaesthetic Agents Sales by Region (2021-2026) & (Tons)
Table 48. APAC Volatile Anaesthetic Agents Sales Market Share by Region (2021-2026)
Table 49. APAC Volatile Anaesthetic Agents Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 51. APAC Volatile Anaesthetic Agents Sales by Application (2021-2026) & (Tons)
Table 52. Europe Volatile Anaesthetic Agents Sales by Country (2021-2026) & (Tons)
Table 53. Europe Volatile Anaesthetic Agents Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 55. Europe Volatile Anaesthetic Agents Sales by Application (2021-2026) & (Tons)
Table 56. Middle East & Africa Volatile Anaesthetic Agents Sales by Country (2021-2026) & (Tons)
Table 57. Middle East & Africa Volatile Anaesthetic Agents Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 59. Middle East & Africa Volatile Anaesthetic Agents Sales by Application (2021-2026) & (Tons)
Table 60. Key Market Drivers & Growth Opportunities of Volatile Anaesthetic Agents
Table 61. Key Market Challenges & Risks of Volatile Anaesthetic Agents
Table 62. Key Industry Trends of Volatile Anaesthetic Agents
Table 63. Volatile Anaesthetic Agents Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Volatile Anaesthetic Agents Distributors List
Table 66. Volatile Anaesthetic Agents Customer List
Table 67. Global Volatile Anaesthetic Agents Sales Forecast by Region (2027-2032) & (Tons)
Table 68. Global Volatile Anaesthetic Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Volatile Anaesthetic Agents Sales Forecast by Country (2027-2032) & (Tons)
Table 70. Americas Volatile Anaesthetic Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Volatile Anaesthetic Agents Sales Forecast by Region (2027-2032) & (Tons)
Table 72. APAC Volatile Anaesthetic Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Volatile Anaesthetic Agents Sales Forecast by Country (2027-2032) & (Tons)
Table 74. Europe Volatile Anaesthetic Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Volatile Anaesthetic Agents Sales Forecast by Country (2027-2032) & (Tons)
Table 76. Middle East & Africa Volatile Anaesthetic Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Volatile Anaesthetic Agents Sales Forecast by Type (2027-2032) & (Tons)
Table 78. Global Volatile Anaesthetic Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Volatile Anaesthetic Agents Sales Forecast by Application (2027-2032) & (Tons)
Table 80. Global Volatile Anaesthetic Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. Baxter Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 82. Baxter Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 83. Baxter Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 84. Baxter Main Business
Table 85. Baxter Latest Developments
Table 86. AbbVie Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 87. AbbVie Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 88. AbbVie Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 89. AbbVie Main Business
Table 90. AbbVie Latest Developments
Table 91. Piramal Critical Care Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 92. Piramal Critical Care Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 93. Piramal Critical Care Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 94. Piramal Critical Care Main Business
Table 95. Piramal Critical Care Latest Developments
Table 96. Fresenius Kabi Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 97. Fresenius Kabi Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 98. Fresenius Kabi Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. Fresenius Kabi Main Business
Table 100. Fresenius Kabi Latest Developments
Table 101. Halocarbon Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 102. Halocarbon Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 103. Halocarbon Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Halocarbon Main Business
Table 105. Halocarbon Latest Developments
Table 106. Aspen Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 107. Aspen Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 108. Aspen Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Aspen Main Business
Table 110. Aspen Latest Developments
Table 111. Pfizer Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 112. Pfizer Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 113. Pfizer Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Pfizer Main Business
Table 115. Pfizer Latest Developments
Table 116. Maruishi Pharmaceutical Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 117. Maruishi Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 118. Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. Maruishi Pharmaceutical Main Business
Table 120. Maruishi Pharmaceutical Latest Developments
Table 121. Jiangsu Hengrui Medicine Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 122. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 123. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. Jiangsu Hengrui Medicine Main Business
Table 125. Jiangsu Hengrui Medicine Latest Developments
Table 126. Lunan Pharmaceutical Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 127. Lunan Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 128. Lunan Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. Lunan Pharmaceutical Main Business
Table 130. Lunan Pharmaceutical Latest Developments
Table 131. Hikma Pharmaceuticals Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 132. Hikma Pharmaceuticals Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 133. Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Hikma Pharmaceuticals Main Business
Table 135. Hikma Pharmaceuticals Latest Developments
Table 136. HeBei YiPin Pharmaceutical Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 137. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 138. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. HeBei YiPin Pharmaceutical Main Business
Table 140. HeBei YiPin Pharmaceutical Latest Developments
Table 141. Dechra Pharmaceuticals Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 142. Dechra Pharmaceuticals Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 143. Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. Dechra Pharmaceuticals Main Business
Table 145. Dechra Pharmaceuticals Latest Developments
Table 146. Life Sciences Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 147. Life Sciences Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 148. Life Sciences Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 149. Life Sciences Main Business
Table 150. Life Sciences Latest Developments
Table 151. Zhejiang AngLiKang Pharmaceutical Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 152. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 153. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 154. Zhejiang AngLiKang Pharmaceutical Main Business
Table 155. Zhejiang AngLiKang Pharmaceutical Latest Developments
Table 156. Linde Healthcare Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 157. Linde Healthcare Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 158. Linde Healthcare Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 159. Linde Healthcare Main Business
Table 160. Linde Healthcare Latest Developments
Table 161. Air Liquide Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 162. Air Liquide Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 163. Air Liquide Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 164. Air Liquide Main Business
Table 165. Air Liquide Latest Developments
Table 166. Messer Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 167. Messer Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 168. Messer Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 169. Messer Main Business
Table 170. Messer Latest Developments
Table 1. Volatile Anaesthetic Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Volatile Anaesthetic Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Heptafluoroane
Table 4. Major Players of Desflurane
Table 5. Major Players of Isoflurane
Table 6. Major Players of Others
Table 7. Global Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 8. Global Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Table 9. Global Volatile Anaesthetic Agents Revenue by Type (2021-2026) & ($ million)
Table 10. Global Volatile Anaesthetic Agents Revenue Market Share by Type (2021-2026)
Table 11. Global Volatile Anaesthetic Agents Sale Price by Type (2021-2026) & (US$/kg)
Table 12. Major Players of Below 3%
Table 13. Major Players of Above 3%
Table 14. Global Volatile Anaesthetic Agents Sales by MAC (2021-2026) & (Tons)
Table 15. Global Volatile Anaesthetic Agents Sales Market Share by MAC (2021-2026)
Table 16. Global Volatile Anaesthetic Agents Revenue by MAC (2021-2026) & ($ million)
Table 17. Global Volatile Anaesthetic Agents Revenue Market Share by MAC (2021-2026)
Table 18. Global Volatile Anaesthetic Agents Sale Price by MAC (2021-2026) & (US$/kg)
Table 19. Global Volatile Anaesthetic Agents Sale by Application (2021-2026) & (Tons)
Table 20. Global Volatile Anaesthetic Agents Sale Market Share by Application (2021-2026)
Table 21. Global Volatile Anaesthetic Agents Revenue by Application (2021-2026) & ($ million)
Table 22. Global Volatile Anaesthetic Agents Revenue Market Share by Application (2021-2026)
Table 23. Global Volatile Anaesthetic Agents Sale Price by Application (2021-2026) & (US$/kg)
Table 24. Global Volatile Anaesthetic Agents Sales by Company (2021-2026) & (Tons)
Table 25. Global Volatile Anaesthetic Agents Sales Market Share by Company (2021-2026)
Table 26. Global Volatile Anaesthetic Agents Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Volatile Anaesthetic Agents Revenue Market Share by Company (2021-2026)
Table 28. Global Volatile Anaesthetic Agents Sale Price by Company (2021-2026) & (US$/kg)
Table 29. Key Manufacturers Volatile Anaesthetic Agents Producing Area Distribution and Sales Area
Table 30. Players Volatile Anaesthetic Agents Products Offered
Table 31. Volatile Anaesthetic Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Volatile Anaesthetic Agents Sales by Geographic Region (2021-2026) & (Tons)
Table 35. Global Volatile Anaesthetic Agents Sales Market Share Geographic Region (2021-2026)
Table 36. Global Volatile Anaesthetic Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Volatile Anaesthetic Agents Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Volatile Anaesthetic Agents Sales by Country/Region (2021-2026) & (Tons)
Table 39. Global Volatile Anaesthetic Agents Sales Market Share by Country/Region (2021-2026)
Table 40. Global Volatile Anaesthetic Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Volatile Anaesthetic Agents Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Volatile Anaesthetic Agents Sales by Country (2021-2026) & (Tons)
Table 43. Americas Volatile Anaesthetic Agents Sales Market Share by Country (2021-2026)
Table 44. Americas Volatile Anaesthetic Agents Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 46. Americas Volatile Anaesthetic Agents Sales by Application (2021-2026) & (Tons)
Table 47. APAC Volatile Anaesthetic Agents Sales by Region (2021-2026) & (Tons)
Table 48. APAC Volatile Anaesthetic Agents Sales Market Share by Region (2021-2026)
Table 49. APAC Volatile Anaesthetic Agents Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 51. APAC Volatile Anaesthetic Agents Sales by Application (2021-2026) & (Tons)
Table 52. Europe Volatile Anaesthetic Agents Sales by Country (2021-2026) & (Tons)
Table 53. Europe Volatile Anaesthetic Agents Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 55. Europe Volatile Anaesthetic Agents Sales by Application (2021-2026) & (Tons)
Table 56. Middle East & Africa Volatile Anaesthetic Agents Sales by Country (2021-2026) & (Tons)
Table 57. Middle East & Africa Volatile Anaesthetic Agents Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Volatile Anaesthetic Agents Sales by Type (2021-2026) & (Tons)
Table 59. Middle East & Africa Volatile Anaesthetic Agents Sales by Application (2021-2026) & (Tons)
Table 60. Key Market Drivers & Growth Opportunities of Volatile Anaesthetic Agents
Table 61. Key Market Challenges & Risks of Volatile Anaesthetic Agents
Table 62. Key Industry Trends of Volatile Anaesthetic Agents
Table 63. Volatile Anaesthetic Agents Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Volatile Anaesthetic Agents Distributors List
Table 66. Volatile Anaesthetic Agents Customer List
Table 67. Global Volatile Anaesthetic Agents Sales Forecast by Region (2027-2032) & (Tons)
Table 68. Global Volatile Anaesthetic Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Volatile Anaesthetic Agents Sales Forecast by Country (2027-2032) & (Tons)
Table 70. Americas Volatile Anaesthetic Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Volatile Anaesthetic Agents Sales Forecast by Region (2027-2032) & (Tons)
Table 72. APAC Volatile Anaesthetic Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Volatile Anaesthetic Agents Sales Forecast by Country (2027-2032) & (Tons)
Table 74. Europe Volatile Anaesthetic Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Volatile Anaesthetic Agents Sales Forecast by Country (2027-2032) & (Tons)
Table 76. Middle East & Africa Volatile Anaesthetic Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Volatile Anaesthetic Agents Sales Forecast by Type (2027-2032) & (Tons)
Table 78. Global Volatile Anaesthetic Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Volatile Anaesthetic Agents Sales Forecast by Application (2027-2032) & (Tons)
Table 80. Global Volatile Anaesthetic Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. Baxter Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 82. Baxter Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 83. Baxter Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 84. Baxter Main Business
Table 85. Baxter Latest Developments
Table 86. AbbVie Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 87. AbbVie Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 88. AbbVie Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 89. AbbVie Main Business
Table 90. AbbVie Latest Developments
Table 91. Piramal Critical Care Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 92. Piramal Critical Care Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 93. Piramal Critical Care Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 94. Piramal Critical Care Main Business
Table 95. Piramal Critical Care Latest Developments
Table 96. Fresenius Kabi Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 97. Fresenius Kabi Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 98. Fresenius Kabi Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. Fresenius Kabi Main Business
Table 100. Fresenius Kabi Latest Developments
Table 101. Halocarbon Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 102. Halocarbon Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 103. Halocarbon Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Halocarbon Main Business
Table 105. Halocarbon Latest Developments
Table 106. Aspen Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 107. Aspen Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 108. Aspen Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Aspen Main Business
Table 110. Aspen Latest Developments
Table 111. Pfizer Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 112. Pfizer Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 113. Pfizer Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Pfizer Main Business
Table 115. Pfizer Latest Developments
Table 116. Maruishi Pharmaceutical Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 117. Maruishi Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 118. Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. Maruishi Pharmaceutical Main Business
Table 120. Maruishi Pharmaceutical Latest Developments
Table 121. Jiangsu Hengrui Medicine Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 122. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 123. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. Jiangsu Hengrui Medicine Main Business
Table 125. Jiangsu Hengrui Medicine Latest Developments
Table 126. Lunan Pharmaceutical Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 127. Lunan Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 128. Lunan Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. Lunan Pharmaceutical Main Business
Table 130. Lunan Pharmaceutical Latest Developments
Table 131. Hikma Pharmaceuticals Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 132. Hikma Pharmaceuticals Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 133. Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Hikma Pharmaceuticals Main Business
Table 135. Hikma Pharmaceuticals Latest Developments
Table 136. HeBei YiPin Pharmaceutical Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 137. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 138. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. HeBei YiPin Pharmaceutical Main Business
Table 140. HeBei YiPin Pharmaceutical Latest Developments
Table 141. Dechra Pharmaceuticals Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 142. Dechra Pharmaceuticals Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 143. Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. Dechra Pharmaceuticals Main Business
Table 145. Dechra Pharmaceuticals Latest Developments
Table 146. Life Sciences Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 147. Life Sciences Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 148. Life Sciences Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 149. Life Sciences Main Business
Table 150. Life Sciences Latest Developments
Table 151. Zhejiang AngLiKang Pharmaceutical Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 152. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 153. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 154. Zhejiang AngLiKang Pharmaceutical Main Business
Table 155. Zhejiang AngLiKang Pharmaceutical Latest Developments
Table 156. Linde Healthcare Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 157. Linde Healthcare Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 158. Linde Healthcare Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 159. Linde Healthcare Main Business
Table 160. Linde Healthcare Latest Developments
Table 161. Air Liquide Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 162. Air Liquide Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 163. Air Liquide Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 164. Air Liquide Main Business
Table 165. Air Liquide Latest Developments
Table 166. Messer Basic Information, Volatile Anaesthetic Agents Manufacturing Base, Sales Area and Its Competitors
Table 167. Messer Volatile Anaesthetic Agents Product Portfolios and Specifications
Table 168. Messer Volatile Anaesthetic Agents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 169. Messer Main Business
Table 170. Messer Latest Developments
LIST OF FIGURES
Figure 1. Picture of Volatile Anaesthetic Agents
Figure 2. Volatile Anaesthetic Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Volatile Anaesthetic Agents Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Volatile Anaesthetic Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Volatile Anaesthetic Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Volatile Anaesthetic Agents Sales Market Share by Country/Region (2025)
Figure 10. Volatile Anaesthetic Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Heptafluoroane
Figure 12. Product Picture of Desflurane
Figure 13. Product Picture of Isoflurane
Figure 14. Product Picture of Others
Figure 15. Global Volatile Anaesthetic Agents Sales Market Share by Type in 2026
Figure 16. Global Volatile Anaesthetic Agents Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Below 3%
Figure 18. Product Picture of Above 3%
Figure 19. Global Volatile Anaesthetic Agents Sales Market Share by MAC in 2026
Figure 20. Global Volatile Anaesthetic Agents Revenue Market Share by MAC (2021-2026)
Figure 21. Volatile Anaesthetic Agents Consumed in Human Use
Figure 22. Global Volatile Anaesthetic Agents Market: Human Use (2021-2026) & (Tons)
Figure 23. Volatile Anaesthetic Agents Consumed in Animal Use
Figure 24. Global Volatile Anaesthetic Agents Market: Animal Use (2021-2026) & (Tons)
Figure 25. Global Volatile Anaesthetic Agents Sale Market Share by Application (2025)
Figure 26. Global Volatile Anaesthetic Agents Revenue Market Share by Application in 2025
Figure 27. Volatile Anaesthetic Agents Sales by Company in 2025 (Tons)
Figure 28. Global Volatile Anaesthetic Agents Sales Market Share by Company in 2025
Figure 29. Volatile Anaesthetic Agents Revenue by Company in 2025 ($ millions)
Figure 30. Global Volatile Anaesthetic Agents Revenue Market Share by Company in 2025
Figure 31. Global Volatile Anaesthetic Agents Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Volatile Anaesthetic Agents Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Volatile Anaesthetic Agents Sales 2021-2026 (Tons)
Figure 34. Americas Volatile Anaesthetic Agents Revenue 2021-2026 ($ millions)
Figure 35. APAC Volatile Anaesthetic Agents Sales 2021-2026 (Tons)
Figure 36. APAC Volatile Anaesthetic Agents Revenue 2021-2026 ($ millions)
Figure 37. Europe Volatile Anaesthetic Agents Sales 2021-2026 (Tons)
Figure 38. Europe Volatile Anaesthetic Agents Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Volatile Anaesthetic Agents Sales 2021-2026 (Tons)
Figure 40. Middle East & Africa Volatile Anaesthetic Agents Revenue 2021-2026 ($ millions)
Figure 41. Americas Volatile Anaesthetic Agents Sales Market Share by Country in 2025
Figure 42. Americas Volatile Anaesthetic Agents Revenue Market Share by Country (2021-2026)
Figure 43. Americas Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Figure 44. Americas Volatile Anaesthetic Agents Sales Market Share by Application (2021-2026)
Figure 45. United States Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Volatile Anaesthetic Agents Sales Market Share by Region in 2025
Figure 50. APAC Volatile Anaesthetic Agents Revenue Market Share by Region (2021-2026)
Figure 51. APAC Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Figure 52. APAC Volatile Anaesthetic Agents Sales Market Share by Application (2021-2026)
Figure 53. China Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. India Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Volatile Anaesthetic Agents Sales Market Share by Country in 2025
Figure 61. Europe Volatile Anaesthetic Agents Revenue Market Share by Country (2021-2026)
Figure 62. Europe Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Figure 63. Europe Volatile Anaesthetic Agents Sales Market Share by Application (2021-2026)
Figure 64. Germany Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. France Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Volatile Anaesthetic Agents Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Volatile Anaesthetic Agents Sales Market Share by Application (2021-2026)
Figure 72. Egypt Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Volatile Anaesthetic Agents in 2026
Figure 78. Manufacturing Process Analysis of Volatile Anaesthetic Agents
Figure 79. Industry Chain Structure of Volatile Anaesthetic Agents
Figure 80. Channels of Distribution
Figure 81. Global Volatile Anaesthetic Agents Sales Market Forecast by Region (2027-2032)
Figure 82. Global Volatile Anaesthetic Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Volatile Anaesthetic Agents Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Volatile Anaesthetic Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Volatile Anaesthetic Agents Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Volatile Anaesthetic Agents Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Volatile Anaesthetic Agents
Figure 2. Volatile Anaesthetic Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Volatile Anaesthetic Agents Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Volatile Anaesthetic Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Volatile Anaesthetic Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Volatile Anaesthetic Agents Sales Market Share by Country/Region (2025)
Figure 10. Volatile Anaesthetic Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Heptafluoroane
Figure 12. Product Picture of Desflurane
Figure 13. Product Picture of Isoflurane
Figure 14. Product Picture of Others
Figure 15. Global Volatile Anaesthetic Agents Sales Market Share by Type in 2026
Figure 16. Global Volatile Anaesthetic Agents Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Below 3%
Figure 18. Product Picture of Above 3%
Figure 19. Global Volatile Anaesthetic Agents Sales Market Share by MAC in 2026
Figure 20. Global Volatile Anaesthetic Agents Revenue Market Share by MAC (2021-2026)
Figure 21. Volatile Anaesthetic Agents Consumed in Human Use
Figure 22. Global Volatile Anaesthetic Agents Market: Human Use (2021-2026) & (Tons)
Figure 23. Volatile Anaesthetic Agents Consumed in Animal Use
Figure 24. Global Volatile Anaesthetic Agents Market: Animal Use (2021-2026) & (Tons)
Figure 25. Global Volatile Anaesthetic Agents Sale Market Share by Application (2025)
Figure 26. Global Volatile Anaesthetic Agents Revenue Market Share by Application in 2025
Figure 27. Volatile Anaesthetic Agents Sales by Company in 2025 (Tons)
Figure 28. Global Volatile Anaesthetic Agents Sales Market Share by Company in 2025
Figure 29. Volatile Anaesthetic Agents Revenue by Company in 2025 ($ millions)
Figure 30. Global Volatile Anaesthetic Agents Revenue Market Share by Company in 2025
Figure 31. Global Volatile Anaesthetic Agents Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Volatile Anaesthetic Agents Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Volatile Anaesthetic Agents Sales 2021-2026 (Tons)
Figure 34. Americas Volatile Anaesthetic Agents Revenue 2021-2026 ($ millions)
Figure 35. APAC Volatile Anaesthetic Agents Sales 2021-2026 (Tons)
Figure 36. APAC Volatile Anaesthetic Agents Revenue 2021-2026 ($ millions)
Figure 37. Europe Volatile Anaesthetic Agents Sales 2021-2026 (Tons)
Figure 38. Europe Volatile Anaesthetic Agents Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Volatile Anaesthetic Agents Sales 2021-2026 (Tons)
Figure 40. Middle East & Africa Volatile Anaesthetic Agents Revenue 2021-2026 ($ millions)
Figure 41. Americas Volatile Anaesthetic Agents Sales Market Share by Country in 2025
Figure 42. Americas Volatile Anaesthetic Agents Revenue Market Share by Country (2021-2026)
Figure 43. Americas Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Figure 44. Americas Volatile Anaesthetic Agents Sales Market Share by Application (2021-2026)
Figure 45. United States Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Volatile Anaesthetic Agents Sales Market Share by Region in 2025
Figure 50. APAC Volatile Anaesthetic Agents Revenue Market Share by Region (2021-2026)
Figure 51. APAC Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Figure 52. APAC Volatile Anaesthetic Agents Sales Market Share by Application (2021-2026)
Figure 53. China Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. India Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Volatile Anaesthetic Agents Sales Market Share by Country in 2025
Figure 61. Europe Volatile Anaesthetic Agents Revenue Market Share by Country (2021-2026)
Figure 62. Europe Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Figure 63. Europe Volatile Anaesthetic Agents Sales Market Share by Application (2021-2026)
Figure 64. Germany Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. France Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Volatile Anaesthetic Agents Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Volatile Anaesthetic Agents Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Volatile Anaesthetic Agents Sales Market Share by Application (2021-2026)
Figure 72. Egypt Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Volatile Anaesthetic Agents Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Volatile Anaesthetic Agents in 2026
Figure 78. Manufacturing Process Analysis of Volatile Anaesthetic Agents
Figure 79. Industry Chain Structure of Volatile Anaesthetic Agents
Figure 80. Channels of Distribution
Figure 81. Global Volatile Anaesthetic Agents Sales Market Forecast by Region (2027-2032)
Figure 82. Global Volatile Anaesthetic Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Volatile Anaesthetic Agents Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Volatile Anaesthetic Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Volatile Anaesthetic Agents Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Volatile Anaesthetic Agents Revenue Market Share Forecast by Application (2027-2032)
